ArticleAmerican journal of cancer research2025

Onvansertib inhibits cell proliferation and increases sensitivity to paclitaxel in uterine serous cancer cells.

Jennifer G Haag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.